Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) CHF-H1
LU0959058974
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) CHF-H1/ LU0959058974 /
NAV19/12/2024 |
Chg.-0.0900 |
Type de rendement |
Focus sur l'investissement |
Société de fonds |
15.1500CHF |
-0.59% |
reinvestment |
Equity
Worldwide
|
Franklin Templeton ▶ |
Objectif d'investissement
The Fund aims to capital appreciation by investing principally in equity securities of biotechnology companies and discovery research firms mainly located in the US.
Opérations
Type de rendement: |
reinvestment |
Fonds Catégorie: |
Equity |
Région de placement: |
Worldwide |
Branche: |
Sector Biotechnology |
Benchmark: |
NASDAQ Biotechnology Index |
Début de l'exercice: |
01/07 |
Dernière distribution: |
- |
Banque dépositaire: |
J.P. Morgan SE, Niederlassung Luxemburg |
Domicile: |
Luxembourg |
Permission de distribution: |
Austria, Germany, Switzerland, United Kingdom, Luxembourg, Czech Republic |
Gestionnaire du fonds: |
Evan McCulloch, Akiva Felt |
Actif net: |
1.49 Mrd.
USD
|
Date de lancement: |
16/08/2013 |
Focus de l'investissement: |
- |
Conditions
Surtaxe d'émission: |
5.75% |
Frais d'administration max.: |
1.50% |
Investissement minimum: |
1,000.00 CHF |
Deposit fees: |
0.14% |
Frais de rachat: |
0.00% |
Prospectus simplifié: |
Télécharger (Version imprimée) |
Société de fonds
Société de fonds: |
Franklin Templeton |
Adresse: |
Schottenring 16, 2.OG, 1010, Wien |
Pays: |
Austria |
Internet: |
www.franklintempleton.at
|
Actifs
Stocks |
|
94.24% |
Bonds |
|
2.92% |
Cash |
|
0.55% |
Autres |
|
2.29% |
Pays
United States of America |
|
77.60% |
Netherlands |
|
6.36% |
United Kingdom |
|
4.10% |
Ireland |
|
3.06% |
Denmark |
|
3.02% |
Canada |
|
0.92% |
France |
|
0.74% |
Cayman Islands |
|
0.71% |
Cash |
|
0.55% |
Germany |
|
0.30% |
Autres |
|
2.64% |
Branches
Pharma/Biotechnology |
|
89.27% |
Healthcare services |
|
4.62% |
Cash |
|
0.55% |
Autres |
|
5.56% |